1-(2,3-Dichlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)ethyl]-1H-indole

• CAT Number: R036539
• CAS Number: 180002-83-9
• Molecular Formula: C23H24Cl2N2O3
• Molecular Weight: 447.356
• Purity: ≥95%
• Synonyms: (2,3-Dichlorophenyl)[5-methoxy-2-methyl-3-[2-(4-morpholinyl)ethyl]-1H-indol-1-yl]methanone; GW 405833; L 768242
• Target: Neuronal Signaling
• Storage: -20°C
• IUPAC Name: (2,3-dichlorophenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-ylethyl)indol-1-yl]methanone
• InChI: InChI=1S/C23H24Cl2N2O3/c1-15-17(8-9-26-10-12-30-13-11-26)19-14-16(29-2)6-7-21(19)27(15)23(28)18-4-3-5-20(24)22(18)25/h3-7,14H,8-13H2,1-2H3
• InChIKey: FSFZRNZSZYDVLI-UHFFFAOYSA-N
• SMILES: CC1=C(C2=C(N1C(=O)C3=C(C(=CC=C3)Cl)Cl)C=CC(=C2)OC)CCN4CCOCC4

GW405833, also klnown as L-768242, is a cannabinoid-2 (CB(2)) receptor-selective agonist. It displays anti-nociceptive activity in models of neuropathic and inflammatory pain.

Reference

1: Mancini I, Brusa R, Quadrato G, Foglia C, Scandroglio P, Silverman LS, Tulshian D, Reggiani A, Beltramo M. Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242. Br J Pharmacol. 2009 Sep;158(1):382-91. doi: 10.1111/j.1476-5381.2009.00154.x. Epub 2009 Jun 22. PubMed PMID: 19552692; PubMed Central PMCID: PMC2795250.2: Marriott KS, Huffman JW. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr Top Med Chem. 2008;8(3):187-204. Review. PubMed PMID: 18289088.3: Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, Reggiani A. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci. 2006 Mar;23(6):1530-8. PubMed PMID: 16553616.4: Huffman JW. CB2 receptor ligands. Mini Rev Med Chem. 2005 Jul;5(7):641-9. Review. PubMed PMID: 16026310.5: Huffman JW. The search for selective ligands for the CB2 receptor. Curr Pharm Des. 2000 Sep;6(13):1323-37. Review. PubMed PMID: 10903395.